Useful resources |
Hydroxyurea for sickle cell disease (Cochrane Review) ABSTRACT Background: Sickle cell disease is one of the most common inherited diseases worldwide. It is associated with lifelong morbidity and a reduced life expectancy. Hydroxyurea, an oral chemotherapeutic drug, is expected to ameliorate some of the clinical problems of . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |